16-1220989-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_021098.3(CACNA1H):c.7057G>C(p.Val2353Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000703 in 1,422,114 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V2353E) has been classified as Likely benign.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.7057G>C | p.Val2353Leu | missense_variant | Exon 35 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.7072G>C | p.Val2358Leu | missense_variant | Exon 34 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.7042G>C | p.Val2348Leu | missense_variant | Exon 34 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.7039G>C | p.Val2347Leu | missense_variant | Exon 34 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.7039G>C | p.Val2347Leu | missense_variant | Exon 35 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.7024G>C | p.Val2342Leu | missense_variant | Exon 35 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.7018G>C | p.Val2340Leu | missense_variant | Exon 35 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.7006G>C | p.Val2336Leu | missense_variant | Exon 34 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.7000G>C | p.Val2334Leu | missense_variant | Exon 34 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000637236.3 | n.*2976G>C | non_coding_transcript_exon_variant | Exon 34 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.*2105G>C | non_coding_transcript_exon_variant | Exon 35 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*4875G>C | non_coding_transcript_exon_variant | Exon 35 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*6501G>C | non_coding_transcript_exon_variant | Exon 33 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.*1998G>C | non_coding_transcript_exon_variant | Exon 36 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.*1916G>C | non_coding_transcript_exon_variant | Exon 35 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.*2636G>C | non_coding_transcript_exon_variant | Exon 36 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.*1724G>C | non_coding_transcript_exon_variant | Exon 36 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.*1691G>C | non_coding_transcript_exon_variant | Exon 36 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.*971G>C | non_coding_transcript_exon_variant | Exon 34 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.7057G>C | non_coding_transcript_exon_variant | Exon 35 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.7024G>C | non_coding_transcript_exon_variant | Exon 35 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.*2173G>C | non_coding_transcript_exon_variant | Exon 35 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000711482.1 | c.*536G>C | 3_prime_UTR_variant | Exon 36 of 36 | ENSP00000518771.1 | |||||
| CACNA1H | ENST00000711485.1 | c.*536G>C | 3_prime_UTR_variant | Exon 35 of 35 | ENSP00000518774.1 | |||||
| CACNA1H | ENST00000711455.1 | c.*536G>C | 3_prime_UTR_variant | Exon 36 of 36 | ENSP00000518768.1 | |||||
| CACNA1H | ENST00000711483.1 | c.*971G>C | 3_prime_UTR_variant | Exon 35 of 35 | ENSP00000518772.1 | |||||
| CACNA1H | ENST00000711456.1 | c.*971G>C | 3_prime_UTR_variant | Exon 34 of 34 | ENSP00000518769.1 | |||||
| CACNA1H | ENST00000637236.3 | n.*2976G>C | 3_prime_UTR_variant | Exon 34 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.*2105G>C | 3_prime_UTR_variant | Exon 35 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*4875G>C | 3_prime_UTR_variant | Exon 35 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*6501G>C | 3_prime_UTR_variant | Exon 33 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.*1998G>C | 3_prime_UTR_variant | Exon 36 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.*1916G>C | 3_prime_UTR_variant | Exon 35 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.*2636G>C | 3_prime_UTR_variant | Exon 36 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.*1724G>C | 3_prime_UTR_variant | Exon 36 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.*1691G>C | 3_prime_UTR_variant | Exon 36 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.*971G>C | 3_prime_UTR_variant | Exon 34 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711488.1 | n.*2173G>C | 3_prime_UTR_variant | Exon 35 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000621827.2 | n.6121+936G>C | intron_variant | Intron 35 of 36 | 6 | ENSP00000518766.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 7.03e-7 AC: 1AN: 1422114Hom.: 0 Cov.: 34 AF XY: 0.00000142 AC XY: 1AN XY: 704430 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
- -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CACNA1H protein function. ClinVar contains an entry for this variant (Variation ID: 1375555). This variant has not been reported in the literature in individuals affected with CACNA1H-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 2353 of the CACNA1H protein (p.Val2353Leu). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at